These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 23637349)

  • 1. Awareness, treatment, and control of LDL cholesterol are lower among U.S. adults with undiagnosed diabetes versus diagnosed diabetes.
    Brown TM; Tanner RM; Carson AP; Yun H; Rosenson RS; Farkouh ME; Woolley JM; Thacker EL; Glasser SP; Safford MM; Muntner P
    Diabetes Care; 2013 Sep; 36(9):2734-40. PubMed ID: 23637349
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prevalence of lipid abnormalities in the United States: the National Health and Nutrition Examination Survey 2003-2006.
    Tóth PP; Potter D; Ming EE
    J Clin Lipidol; 2012; 6(4):325-30. PubMed ID: 22836069
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Implications of cardiac risk and low-density lipoprotein cholesterol distributions in the United States for the diagnosis and treatment of dyslipidemia: data from National Health and Nutrition Examination Survey 1999 to 2002.
    Keevil JG; Cullen MW; Gangnon R; McBride PE; Stein JH
    Circulation; 2007 Mar; 115(11):1363-70. PubMed ID: 17353444
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Trends in utilization of lipid- and blood pressure-lowering agents and goal attainment among the U.S. diabetic population, 1999-2008.
    Kuznik A; Mardekian J
    Cardiovasc Diabetol; 2011 Apr; 10():31. PubMed ID: 21496321
    [TBL] [Abstract][Full Text] [Related]  

  • 5. LDL-C goal attainment among patients newly diagnosed with coronary heart disease or diabetes in a commercial HMO.
    Nag SS; Daniel GW; Bullano MF; Kamal-Bahl S; Sajjan SG; Hu H; Alexander C
    J Manag Care Pharm; 2007 Oct; 13(8):652-63. PubMed ID: 17970603
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Potential effects of reclassifying CKD as a coronary heart disease risk equivalent in the US population.
    Foster MC; Rawlings AM; Marrett E; Neff D; Grams ME; Kasiske BL; Willis K; Inker LA; Coresh J; Selvin E
    Am J Kidney Dis; 2014 May; 63(5):753-60. PubMed ID: 24369751
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Joint distribution of non-HDL and LDL cholesterol and coronary heart disease risk prediction among individuals with and without diabetes.
    Liu J; Sempos C; Donahue RP; Dorn J; Trevisan M; Grundy SM
    Diabetes Care; 2005 Aug; 28(8):1916-21. PubMed ID: 16043732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Vital signs: prevalence, treatment, and control of high levels of low-density lipoprotein cholesterol--United States, 1999-2002 and 2005-200.
    Centers for Disease Control and Prevention (CDC)
    MMWR Morb Mortal Wkly Rep; 2011 Feb; 60(4):109-14. PubMed ID: 21293326
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence of lower extremity diseases associated with normal glucose levels, impaired fasting glucose, and diabetes among U.S. adults aged 40 or older.
    Gregg EW; Gu Q; Williams D; de Rekeneire N; Cheng YJ; Geiss L; Engelgau M
    Diabetes Res Clin Pract; 2007 Sep; 77(3):485-8. PubMed ID: 17306411
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Trends in ATP-III-defined high blood cholesterol prevalence, awareness, treatment and control among U.S. adults.
    Hyre AD; Muntner P; Menke A; Raggi P; He J
    Ann Epidemiol; 2007 Jul; 17(7):548-55. PubMed ID: 17395483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hypercholesterolemia in diabetes and glucose intolerance in the U.S. population.
    Harris MI
    Diabetes Care; 1991 May; 14(5):366-74. PubMed ID: 2060448
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Undiagnosed diabetes is prevalent in younger adults and associated with a higher risk cardiometabolic profile compared to diagnosed diabetes.
    Lee YH; Armstrong EJ; Kim G; Oh J; Kang SM; Lee BW; Ahn CW; Cha BS; Lee HC; Mantzoros CS; Kang ES
    Am Heart J; 2015 Oct; 170(4):760-769.e2. PubMed ID: 26386800
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Trends in the prevalence and ratio of diagnosed to undiagnosed diabetes according to obesity levels in the U.S.
    Gregg EW; Cadwell BL; Cheng YJ; Cowie CC; Williams DE; Geiss L; Engelgau MM; Vinicor F
    Diabetes Care; 2004 Dec; 27(12):2806-12. PubMed ID: 15562189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Coronary heart disease in patients with low LDL-cholesterol: benefit of pravastatin in diabetics and enhanced role for HDL-cholesterol and triglycerides as risk factors.
    Sacks FM; Tonkin AM; Craven T; Pfeffer MA; Shepherd J; Keech A; Furberg CD; Braunwald E
    Circulation; 2002 Mar; 105(12):1424-8. PubMed ID: 11914249
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Low-density lipoprotein cholesterol goal attainment rates in high-risk patients with cardiovascular diseases and diabetes mellitus in Korea: a retrospective cohort study.
    Yang YS; Yang BR; Kim MS; Hwang Y; Choi SH
    Lipids Health Dis; 2020 Jan; 19(1):5. PubMed ID: 31926562
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A cascade of care for diabetes in the United States: visualizing the gaps.
    Ali MK; Bullard KM; Gregg EW; Del Rio C
    Ann Intern Med; 2014 Nov; 161(10):681-9. PubMed ID: 25402511
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identifying Trends in Undiagnosed Diabetes in U.S. Adults by Using a Confirmatory Definition: A Cross-sectional Study.
    Selvin E; Wang D; Lee AK; Bergenstal RM; Coresh J
    Ann Intern Med; 2017 Dec; 167(11):769-776. PubMed ID: 29059691
    [TBL] [Abstract][Full Text] [Related]  

  • 18. American Diabetes Association diabetes diagnostic criteria, advancing age, and cardiovascular disease risk profiles: results from the Third National Health and Nutrition Examination Survey.
    Resnick HE; Harris MI; Brock DB; Harris TB
    Diabetes Care; 2000 Feb; 23(2):176-80. PubMed ID: 10868827
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Low-density lipoprotein cholesterol reduction and goal achievement with ezetimibe/simvastatin versus atorvastatin or rosuvastatin in patients with diabetes, metabolic syndrome, or neither disease, stratified by National Cholesterol Education Program risk category.
    Polis AB; Abate N; Catapano AL; Ballantyne CM; Davidson MH; Smugar SS; Tershakovec AM
    Metab Syndr Relat Disord; 2009 Dec; 7(6):601-10. PubMed ID: 19929597
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.